OR WAIT null SECS
March 05, 2020
FDA issued a notice to drug compounders regarding the transition of licensure of biologics to the Public Health Service Act.
A guidance document answers questions regarding the transition of biologics applications from under the FD&C Act to the PHS Act.
March 02, 2020
Assays can provide a useful tool in determining the potential toxicity of drugs throughout the development cycle.
Metrology has the potential to not only prevent harm to patients but also to support innovative therapeutic options.
The huge potential of biopharma is presenting an important epoch for outsourcing partners that can support the development and manufacture of biologics in an efficient way.
Can investing in early formulation studies drive a new therapy successfully across the commercialization finish line?
Formulating fixed-dose combination drugs proves more complex than simply adding one ingredient to another.
February 27, 2020
Perrigo will be producing a limited amount of the generic inhaler medication but will accelerate production to meet future demands in collaboration with Catalent.
February 21, 2020
Researchers at the Technical University of Munich (TUM) have discovered a way of continuously and precisely dosing active agents using an oil-hydrogel mixture.
As the date for transitioning the approval of biologic drug to a new pathway comes closer, FDA publishes a final rule and answers questions on the pathway changes.